Stock Research for FOLD

FOLD

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

FOLD Stock Chart & Research Data

The FOLD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the FOLD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


FOLD Due diligence Resources & Stock Charts

The FOLD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View FOLD Detailed Price Forecast - CNN Money CNN View FOLD Detailed Summary - Google Finance
Yahoo View FOLD Detailed Summary - Yahoo! Finance Zacks View FOLD Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View FOLD Trends & Analysis - Trade-Ideas Barrons View FOLD Major Holders - Barrons
NASDAQ View FOLD Call Transcripts - NASDAQ Seeking View FOLD Breaking News & Analysis - Seeking Alpha
Spotlight View FOLD Annual Report - CompanySpotlight.com OTC Report View FOLD OTC Short Report - OTCShortReport.com
TradeKing View FOLD Fundamentals - TradeKing Charts View FOLD SEC Filings - Bar Chart
WSJ View Historical Prices for FOLD - The WSJ Morningstar View Performance/Total Return for FOLD - Morningstar
MarketWatch View the Analyst Estimates for FOLD - MarketWatch CNBC View the Earnings History for FOLD - CNBC
StockMarketWatch View the FOLD Earnings - StockMarketWatch MacroAxis View FOLD Buy or Sell Recommendations - MacroAxis
Bullish View the FOLD Bullish Patterns - American Bulls Short Pains View FOLD Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View FOLD Stock Mentions - StockTwits PennyStocks View FOLD Stock Mentions - PennyStockTweets
Twitter View FOLD Stock Mentions - Twitter Invest Hub View FOLD Investment Forum News - Investor Hub
Yahoo View FOLD Stock Mentions - Yahoo! Message Board Seeking Alpha View FOLD Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for FOLD - SECform4.com Insider Cow View Insider Transactions for FOLD - Insider Cow
CNBC View FOLD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for FOLD - OTC Markets
Yahoo View Insider Transactions for FOLD - Yahoo! Finance NASDAQ View Institutional Holdings for FOLD - NASDAQ


Stock Charts

FinViz View FOLD Stock Insight & Charts - FinViz.com StockCharts View FOLD Investment Charts - StockCharts.com
BarChart View FOLD Stock Overview & Charts - BarChart Trading View View FOLD User Generated Charts - Trading View


Latest Financial News for FOLD

Amicus Therapeutics Honors Fabry Disease Awareness Month and International Pompe Day
Posted on Tuesday April 17, 2018

CRANBURY, N.J., April 17, 2018-- Amicus Therapeutics is participating in several activities in April to honor Fabry Disease Awareness Month and International Pompe Day. The Fabry community has designated ...


Report: Developing Opportunities within Amicus Therapeutics, Rite Aid, Navient, ProPetro Holding, Pfizer, and Sysco — Future Expectations, Projections Moving into 2018
Posted on Monday April 16, 2018

NEW YORK, April 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...


Analyst Ratings for UniQure and Its Peers in April 2018
Posted on Friday April 13, 2018

UniQure (QURE) is a leading company in the field of gene therapy. It has a focused pipeline of innovative gene therapies developed both internally and through collaboration for cardiovascular diseases. It has established clinical proof of concept for its lead indication, hemophilia B, and has achieved preclinical proof of concept in Huntington’s disease.


Analysts Rate Voyager Therapeutics and Its Peers in April
Posted on Friday April 13, 2018

Voyager Therapeutics (VYGR) is a clinical-stage gene therapy company with a focus on developing treatments for severe neurological diseases. It focuses on those neurological diseases for which an adeno-associated virus (or AAV) gene therapy can reduce the symptoms experienced by patients. Of the 13 analysts covering Voyager Therapeutics in April 2018, five have given the stock “strong buy” ratings, five have given it “buy” ratings, and three have given it “hold” ratings.


Enter a stock symbol to view the stock details.